| Compound | Gonadorelin |
|---|---|
| Category | Native GnRH |
| Class | Other Injectables |
| Evidence tier | Approved medicine |
| WADA status | Prohibited in sport (or falls under a prohibited class) — see the WADA reference table |
| Sold on this site | No — this is a reference database |
Overview
Gonadorelin is catalogued here as a native gnrh and graded at the "Approved medicine" evidence tier. This compound exists as an approved medicine in at least one major jurisdiction. Approval applies to specific, labeled indications and to the regulated product — not to compounded or research-grade copies.
Synthetic native gonadotropin-releasing hormone, approved historically for diagnostic stimulation of the pituitary-gonadal axis.
Mechanism of Action
Pulsatile GnRH stimulates FSH/LH release; continuous exposure paradoxically suppresses the axis — the basis of GnRH agonist drugs.
Research and Evidence
Established diagnostic pharmacology; therapeutic use has largely moved to longer-acting analogs.
Safety and Side Effects
Approved-product use is characterized; it is prohibited in sport as a releasing factor.
Frequently Asked Questions
What is the evidence tier of Gonadorelin?
Gonadorelin is graded "Approved medicine" on this site. This compound exists as an approved medicine in at least one major jurisdiction. Approval applies to specific, labeled indications and to the regulated product — not to compounded or research-grade copies.
Is Gonadorelin an approved medicine?
Gonadorelin exists as an approved medicine in at least one major jurisdiction — but approval covers the regulated product and its labeled indications only. Compounded or research-grade versions of the same molecule are not the approved product.
Where can I read the primary studies for Gonadorelin?
The references section at the end of this entry links the key primary sources — regulator labels, trial registrations, and peer-reviewed papers. Our "How to Read a Peptide Study" guide explains how to evaluate them.
References
Evidence tier: Approved medicine · Last reviewed: 2026-09-05 · Sources cited below.